Kairos Pharma Ltd. has announced a change in its certifying accountants as part of its recent financial reporting update. On April 23, 2025, the company's audit committee appointed Weinberg and Company, P.A. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision resulted in the dismissal of Marcum LLP, effective on the same date. Marcum's audit reports for the years ended December 31, 2024, and 2023 included no adverse opinions or disclaimers, although the 2023 report noted uncertainty regarding the company's ability to continue as a going concern. There were no disagreements or reportable events with Marcum regarding accounting principles or practices. This transition follows the identification of material weaknesses in internal controls over financial reporting for the fiscal years 2024 and 2023.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。